--- title: Buy Olumiant (Baricitinib) 4mg Pills Online description: Olumiant (Baricitinib) 4mg pills treat rheumatoid arthritis and alopecia. Order from our secure pharmacy for trusted autoimmune treatment. type: product language: en url: https://liabilis.com/order-olumiant-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 964.24 price_max: 3919.99 currency: USD offers: - name: 4mg x 7 pills price: 964.24 - name: 4mg x 14 pills price: 1888.59 - name: 4mg x 28 pills price: 3919.99 --- # Buy Olumiant (Baricitinib) 4mg Pills Online Olumiant contains the active ingredient Baricitinib and is used to treat moderate to severe rheumatoid arthritis and certain cases of alopecia areata. This JAK inhibitor works by reducing inflammation and immune system activity, making it suitable for adults with autoimmune conditions. Our pharmacy offers reliable access to Olumiant in 4mg pill form with discreet packaging and verified quality. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **4mg** | 7 pills | **$964.24** | $137.75 | In Stock | | **4mg** | 14 pills | **$1888.59** | $134.90 | In Stock | | **4mg** | 28 pills | **$3919.99** | $140.00 | In Stock | [Buy Now](https://liabilis.com/order-olumiant-online-en.html) ## Introduction Olumiant (generic name Baricitinib) is an oral medication supplied as a 4 mg tablet. It belongs to the class of Janus kinase (JAK) inhibitors and is primarily prescribed for moderate to severe rheumatoid arthritis that has not responded adequately to conventional disease-modifying antirheumatic drugs (DMARDs). Baricitinib’s anti-inflammatory activity also supports its use in certain other approved autoimmune conditions. ## Quick Reference Facts ``` **Active Ingredient** : Baricitinib **Form** : pill 4 mg **Primary Uses** : • Rheumatoid arthritis • Severe atopic dermatitis (approved in some regions) • COVID-19 hospitalization (conditional authorization in selected countries) ``` ## What is Olumiant? Olumiant is the generic version of medications that contain the active compound Baricitinib. The drug is manufactured by several licensed producers and is distributed worldwide under generic labeling. Marketed under brand names such as Olumiant and other regional trademarks, the generic formulation provides the same molecular entity, dosage strength, and therapeutic effect as its branded counterparts. Because it is a generic product, it offers a cost-effective alternative while meeting the same regulatory standards for safety, efficacy, and quality. ## How Olumiant Works Baricitinib selectively inhibits Janus kinase 1 and Janus kinase 2 (JAK1/JAK2), key enzymes that transmit signals from cytokine receptors to the cell nucleus. By blocking these pathways, Olumiant reduces the production of inflammatory mediators such as interleukin-6, interferon-γ, and tumor necrosis factor-α. The resulting dampening of the immune response alleviates joint inflammation, pain, and tissue damage characteristic of rheumatoid arthritis. Baricitinib is rapidly absorbed after oral administration, reaching peak plasma concentrations within 1-3 hours. It is metabolised minimally by the liver and is eliminated primarily unchanged in the urine, giving it a half-life of approximately 12 hours, which supports once-daily dosing. ## Conditions Treated with Olumiant - **Rheumatoid arthritis** - In patients who have an inadequate response to methotrexate or other csDMARDs, Olumiant reduces joint swelling, pain, and radiographic progression. - **Severe atopic dermatitis** - For adults with moderate-to-severe eczema unresponsive to topical therapies, the drug mitigates erythema and pruritus by curbing cytokine-driven skin inflammation. - **COVID-19 requiring hospitalisation** - In certain jurisdictions, Olumiant is authorised for adult patients with COVID-19 who need supplemental oxygen, where it helps attenuate the cytokine storm that can worsen respiratory failure. ## Is Olumiant the Right Medication for You? Olumiant is most appropriate for adults with confirmed rheumatoid arthritis who have failed at least one conventional DMARD, or for those with severe atopic dermatitis not controlled by topical agents. It is also considered in specific COVID-19 treatment protocols under specialist supervision. Contraindications include active serious infections, severe hepatic impairment, and known hypersensitivity to baricitinib or any excipients. Caution is advised in patients with a history of venous thromboembolism, malignancy, or chronic kidney disease (eGFR < 30 mL/min/1.73 m²). Pregnant or breastfeeding women should avoid Olumiant unless the potential benefit justifies the risk. Decision-making should involve a rheumatologist or specialist familiar with the patient’s overall health profile. ## Buying Olumiant from [our online pharmacy](https://liabilis.com/order-olumiant-online-en.html) ### Why Choose Our Service? Accessing Olumiant can be challenging due to insurance restrictions or local supply constraints. Our platform offers a straightforward, cost-effective way to obtain the medication without compromising quality. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every batch is sourced from manufacturers that comply with Good Manufacturing Practices (GMP) and undergo independent verification. ### Pricing & Access Because Olumiant is available as a generic product, you benefit from pricing that is often 30-50 % lower than branded alternatives. Our pharmacy service makes the medication reachable for patients in regions where it may otherwise be scarce. ### Discreet Delivery Orders are packaged in plain, tamper-evident containers and shipped via express delivery (typically within 7 days) or standard airmail (approximately 3 weeks). Your privacy is protected at every step. ## Use: Dosing, Missed Dose, Overdose - **Standard dosing**: One 4 mg tablet taken orally once daily, with or without food. - **Missed dose**: If you realise a dose was missed within 12 hours, take it as soon as you remember. Skip the missed dose if it is almost time for the next scheduled dose; do not double-dose. - **Overdose**: Contact emergency services or a poison-control center immediately. Signs of overdose may include severe fatigue, dizziness, or abnormal bleeding. Provide the exact amount taken if known. - **Administration tips**: Swallow the tablet whole; do not crush or chew. Limit alcohol intake, as excessive consumption can increase infection risk. Avoid operating heavy machinery until you know how Olumiant affects you, especially during the first few days of treatment. ## Safety Information ### ⚠️ Who Should Not Take Olumiant - Patients with active, untreated serious bacterial, fungal, or viral infections. - Individuals with known hypersensitivity to baricitinib or any tablet excipients. - Those with a history of thrombosis (deep-vein thrombosis, pulmonary embolism) unless specifically advised by a specialist. ### Common Side Effects - Upper respiratory tract infections (≈ 20 %); usually mild and self-limiting. - Nausea, headache, and mild elevations in liver enzymes; monitor with routine labs. ### Serious Side Effects (Seek Immediate Medical Help) - New or worsening blood clots (leg swelling, suddenness of breath, chest pain). - Severe infections such as tuberculosis, bacterial sepsis, or opportunistic fungal infections. - Significant drops in blood cell counts (anemia, neutropenia, thrombocytopenia) leading to easy bruising or prolonged bleeding. ### Drug & Food Interactions - **Strong CYP3A4 inhibitors** (e.g., ketoconazole, ritonavir) may increase baricitinib levels; dose adjustment may be required. - **Live vaccines** should be avoided while on Olumiant because of immunosuppression. - **Anticoagulants** (warfarin, direct oral anticoagulants) may have additive bleeding risk; monitor coagulation parameters. ## Off-Label and Investigational Uses of Olumiant - **Alopecia areata** - Small open-label studies suggest baricitinib may promote hair regrowth by suppressing autoimmune attack on hair follicles. - **Systemic lupus erythematosus (SLE)** - Early-phase trials have examined JAK inhibition for lupus nephritis and cutaneous disease, showing modest benefit in disease activity scores. - **Idiopathic pulmonary fibrosis** - Pre-clinical data indicate potential antifibrotic effects; clinical investigation is ongoing. These applications have not received regulatory approval; any off-label use must be managed by a qualified healthcare professional. ## Storage & Handling - Store Olumiant tablets at 20-25 °C (68-77 °F) in a dry place, protected from light and moisture. - Do not freeze. - Keep the container tightly closed and out of reach of children. - Dispose of unused tablets according to local pharmacy waste guidelines or return to a medication take-back program. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Olumiant?** Yes. Keep the medication in its original packaging with a copy of the prescription or a doctor’s note, and be prepared to show it at customs if requested. - **Should I take Olumiant with food?** Olumiant can be taken with or without meals; food does not markedly affect its absorption. - **Is it safe to receive the flu vaccine while on Olumiant?** Inactivated (non-live) influenza vaccines are generally considered safe, but efficacy may be reduced; discuss timing with your physician. **Product & Formulation Details** - **What do Olumiant tablets look like?** The generic 4 mg tablets are round, white, and bear the imprint “4 MG”. Appearance may vary slightly between manufacturers. - **Are there any inactive ingredients I should be aware of?** Common excipients include lactose, silicon dioxide, and magnesium stearate. Patients with severe lactose intolerance should consult their clinician. **Regulatory & Safety Nuances** - **Will Olumiant appear on a standard drug test for athletes?** Baricitinib is not listed as a prohibited substance by major anti-doping agencies, but athletes should verify with their governing body. - **Can seniors over 75 years safely use Olumiant?** Older adults may have a higher risk of infections and thrombosis; dose adjustments and close monitoring are advisable. - **Is Olumiant approved for use in children?** Current approvals are limited to adult populations; pediatric use remains investigational. **Scientific & Clinical Curiosity** - **How was baricitinib originally discovered?** The compound was identified through high-throughput screening of JAK inhibitors at Eli Lilly, with subsequent optimisation for selectivity and oral bioavailability. - **What major clinical trial supported its approval for rheumatoid arthritis?** The Phase III RA-BETTER trial demonstrated significant improvement in ACR20 response rates versus placebo when added to methotrexate. - **Does Olumiant have a patent still in force?** Original patents on baricitinib have expired in many jurisdictions, allowing generic manufacturers to market the drug. ## Glossary **Janus kinase (JAK)** : A family of intracellular enzymes that mediate signaling from cytokine receptors to the nucleus, influencing immune and inflammatory responses. **Biologic DMARD** : A disease-modifying antirheumatic drug derived from living cells (e.g., monoclonal antibodies) used to target specific components of the immune system. **Half-life** : The time required for the plasma concentration of a drug to decrease by 50 %; for baricitinib it is about 12 hours. **eGFR** : Estimated glomerular filtration rate, a measure of kidney function used to adjust dosing of renally cleared drugs. ## Disclaimer The information provided about **Olumiant** is for general knowledge only. It does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. [our online pharmacy](https://liabilis.com/order-olumiant-online-en.html) offers access to **Olumiant** for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.